138 related articles for article (PubMed ID: 10325833)
1. Coating of extracorporeal circuit with heparin does not prevent sequestration of propofol in vitro.
Hammarén E; Rosenberg PH; Hynynen M
Br J Anaesth; 1999 Jan; 82(1):38-40. PubMed ID: 10325833
[TBL] [Abstract][Full Text] [Related]
2. Propofol sequestration within the extracorporeal circuit.
Hynynen M; Hammarén E; Rosenberg PH
Can J Anaesth; 1994 Jul; 41(7):583-8. PubMed ID: 8087906
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
[TBL] [Abstract][Full Text] [Related]
4. Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation.
Borowiec J; Jaramillo A; Venge P; Nilsson L; Thelin S
Cardiovasc Surg; 1997 Dec; 5(6):568-73. PubMed ID: 9423940
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
6. The effect of Diprivan (propofol) on phosphorylcholine surfaces during cardiopulmonary bypass--an in vitro investigation.
Myers GJ; Voorhees C; Eke B; Johnstone R
Perfusion; 2009 Sep; 24(5):349-55. PubMed ID: 19939908
[TBL] [Abstract][Full Text] [Related]
7. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
8. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit.
Moen O; Fosse E; Bråten J; Andersson C; Høgåsen K; Mollnes TE; Venge P; Kierulf P
Perfusion; 1996 Mar; 11(2):113-23. PubMed ID: 8740352
[TBL] [Abstract][Full Text] [Related]
9. Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits.
Borowiec JW; Venge P; Henze A; Nilsson B; Stiernström H
Thorac Cardiovasc Surg; 1997 Dec; 45(6):295-301. PubMed ID: 9477462
[TBL] [Abstract][Full Text] [Related]
10. Prospects for clinical applications of polymer-coated haemoconcentrator on extracorporeal circuit in cardiopulmonary bypass surgeries.
Tagaya M; Takahashi S; Matsuda M; Takasaki T; Hamaishi M; Hara K
Int J Artif Organs; 2016 Oct; 39(8):415-420. PubMed ID: 27646632
[TBL] [Abstract][Full Text] [Related]
11. Heparin-coated cardiopulmonary bypass circuits.
Gravlee GP
J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):213-22. PubMed ID: 8204814
[TBL] [Abstract][Full Text] [Related]
12. Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model.
Scholz T; Solberg R; Okkenhaug C; Videm V; Gallimore MJ; Mathisen O; Pedersen T; Mollnes TE; Bergan A; Søreide O; Klintmalm GB; Aasen AO
Perfusion; 2001 Jul; 16(4):285-92. PubMed ID: 11486847
[TBL] [Abstract][Full Text] [Related]
13. PMEA polymer-coated PVC tubing maintains anti-thrombogenic properties during in vitro whole blood circulation.
Yoshizaki T; Tabuchi N; van Oeveren W; Shibamiya A; Koyama T; Sunamori M
Int J Artif Organs; 2005 Aug; 28(8):834-40. PubMed ID: 16211534
[TBL] [Abstract][Full Text] [Related]
14. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits.
Gunaydin S; Mccusker K; Vijay V
J Extra Corpor Technol; 2005 Sep; 37(3):290-5. PubMed ID: 16350383
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of new surface coatings for extracorporeal circulation.
Baksaas ST; Videm V; Fosse E; Karlsen H; Pedersen T; Mollnes TE; Hagve TA; Svennevig JL
Perfusion; 1999 Jan; 14(1):11-9. PubMed ID: 10074642
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo testing of heparin-coated extracorporeal circuits: bovine experiments.
Weerwind PW; van der Veen FH; Lindhout T; de Jong DS; Cahalan PT
Int J Artif Organs; 1998 May; 21(5):291-8. PubMed ID: 9684912
[TBL] [Abstract][Full Text] [Related]
17. Long-term extracorporeal blood bypass in dogs at low flows without systemic heparinization. Heparin-coated versus uncoated circuits.
van der Hulst VP; Gründeman PF; Moulijn AC; Rutten PJ; Klopper PJ
ASAIO Trans; 1991; 37(4):577-83. PubMed ID: 1768492
[TBL] [Abstract][Full Text] [Related]
18. Improvement of bypass circuit biocompatibility: comparison and combination of heparin-coated circuit and nitric oxide gas infusion.
Hayashi Y; Sawa Y; Hirata N; Nishimura M; Ueda H; Naka Y; Yamaguchi T; Ohtake S; Matsuda H
J Card Surg; 2002; 17(6):477-84. PubMed ID: 12643456
[TBL] [Abstract][Full Text] [Related]
19. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C
Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
[TBL] [Abstract][Full Text] [Related]
20. Issues of biocompatibility: heparin-coated extracorporeal circuit.
Hsu LC
Int Anesthesiol Clin; 1996; 34(2):109-22. PubMed ID: 8799749
[No Abstract] [Full Text] [Related]
[Next] [New Search]
